Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis Multi Drug Resistant Active”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Looking for participantsNCT02354014
What this trial is testing

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Janssen Research & Development, LLC 60
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Testing effectiveness (Phase 2)Looking for participantsNCT05534750
What this trial is testing

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Who this might be right for
TuberculosisMultidrug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 60
Large-scale testing (Phase 3)WithdrawnNCT02975570
What this trial is testing

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Who this might be right for
Tuberculosis Multi Drug Resistant Active
Boston University
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486024
What this trial is testing

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Who this might be right for
MDR-TBTuberculosis Multi Drug Resistant ActiveAntibiotic Resistance+1 more
Assistance Publique - Hôpitaux de Paris 55
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Testing effectiveness (Phase 2)Study completedNCT04608955
What this trial is testing

Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081

Who this might be right for
Pulmonary Tuberculosis
Shanghai Jiatan Pharmatech Co., Ltd 99
Not applicableLooking for participantsNCT01212003
What this trial is testing

Training Protocol on the Natural History of Tuberculosis

Who this might be right for
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Study completedNCT00449644
What this trial is testing

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 208